Request Deal Involvement
Amicus Therapeutics to acquire Celenex and 10 gene therapy programs for $100m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
RBC Capital Markets
legal advisors
Fenwick & West
legal advisors
Skadden Arps Slate Meagher & Flom
pr advisors
Pure Communications
or
Principals
target
CELENEX
target
10 GENE THERAPY PROGRAMS
bidder
AMICUS THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite